Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Lo

Showing results (21-30 of 236) with videos related to

Pageof 24
Sort By:
American Family Physician|September 15, 2005
Statin therapy in patients with type 2 diabetesVincent Lo, John Noviasky, Joan Nashelsky
Pharmacoepidemiology and Drug Safety|April 17, 2007
The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safetyVincent Lo Re, Brian L Strom
Annals of Internal Medicine|April 17, 2002
William of Occam and Occam's razorVincent Lo Re, Lisa M Bellini
American Family Physician|August 20, 2003
Prevention of malaria in travelersVincent Lo Re, Stephen J Gluckman
American Family Physician|July 21, 2004
Travel immunizationsVincent Lo Re, Stephen J Gluckman
Journal of Medical Biography|July 18, 2006
William Pepper Jr, MD (1843-1898): portrait of a nineteenth-century medical educatorVincent Lo Re, Lisa M Bellini
Pharmacoepidemiology and Drug Safety|May 25, 2022
Profiling real-world data sources for pharmacoepidemiologic research: A call for papersXiaojuan Li, Vincent Lo Re, Sengwee Toh
The Annals of Applied Statistics|October 19, 2020
A SEMIPARAMETRIC MODELING APPROACH USING BAYESIAN ADDITIVE REGRESSION TREES WITH AN APPLICATION TO EVALUATE HETEROGENEOUS TREATMENT EFFECTSBret Zeldow, Vincent Lo Re, Jason Roy
The Journal of Family Practice|April 4, 2007
Clinical inquiries. Does warfarin prevent venous thromboembolic events in aPL-positive patients?Michael F Mazzone, Barbara Jamieson, Vincent Lo
The Journal of Family Practice|March 3, 2006
When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis?Vincent Lo, Susan E Meadows, Joseph Saseen
Pageof 24

Showing results (21-30 of 236) with videos related to

Sort By:
Pageof 24
American Family Physician|September 15, 2005
Statin therapy in patients with type 2 diabetesVincent Lo, John Noviasky, Joan Nashelsky
Pharmacoepidemiology and Drug Safety|April 17, 2007
The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safetyVincent Lo Re, Brian L Strom
Annals of Internal Medicine|April 17, 2002
William of Occam and Occam's razorVincent Lo Re, Lisa M Bellini
American Family Physician|August 20, 2003
Prevention of malaria in travelersVincent Lo Re, Stephen J Gluckman
American Family Physician|July 21, 2004
Travel immunizationsVincent Lo Re, Stephen J Gluckman
Journal of Medical Biography|July 18, 2006
William Pepper Jr, MD (1843-1898): portrait of a nineteenth-century medical educatorVincent Lo Re, Lisa M Bellini
Pharmacoepidemiology and Drug Safety|May 25, 2022
Profiling real-world data sources for pharmacoepidemiologic research: A call for papersXiaojuan Li, Vincent Lo Re, Sengwee Toh
The Annals of Applied Statistics|October 19, 2020
A SEMIPARAMETRIC MODELING APPROACH USING BAYESIAN ADDITIVE REGRESSION TREES WITH AN APPLICATION TO EVALUATE HETEROGENEOUS TREATMENT EFFECTSBret Zeldow, Vincent Lo Re, Jason Roy
The Journal of Family Practice|April 4, 2007
Clinical inquiries. Does warfarin prevent venous thromboembolic events in aPL-positive patients?Michael F Mazzone, Barbara Jamieson, Vincent Lo
The Journal of Family Practice|March 3, 2006
When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis?Vincent Lo, Susan E Meadows, Joseph Saseen
Pageof 24